Padilla M, Mayorga R, Carrasco F, Bedregal T, Bobadilla F, Rondón C, Chaman J

Idioma: Ingles.
Referencias bibliográficas: 30
Paginas: 222-227
Archivo PDF: 85.47 Kb.

RESUMEN

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Czaja A, Manns M. Advances in the diagnosis, pathogenesis and management of autoimmune hepatitis. Gastroenterology 2010; 139: 58-72.

2. Verslype C, George C, Buchel E, Nevens F, Van Steenbergen W, Fevery J. Diagnosis and treatment of autoimmune hepatitis at age 65 and older. Aliment Pharmacol Ther 2005; 21: 695-9.

3. Tripathi D, Neuberger J. Autoimmune hepatitis and liver transplantation: Indications, results and management of recurrent disease. Semin Liver Dis 2009; 29: 286-96.

4. Molmenti EP, Netto GJ, Murray NG, Smith DM, Molmenti H, Crippin JS, Hoover TC. Incidence and recurrence of autoimmune/ alloimmune hepatitis in liver transplant recipients. Liver Transpl 2002; 8: 519-26.

5. Duclos-Vallee J, Sebagh M. Recurrence of autoimmune disease, primary sclerosing cholangitis, primary biliary cirrhosis and autoimmune hepatitis after liver transplantation. Liver Transpl 2009; 15: S25-S34.

6. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, Chapman RW, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-38.

7. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-9.

8. Decock S, McGee P, Hirschfield GM. Autoimmune liver disease for the non-specialist. BMJ 2009; 339: b3305.

9. Manns M, Czaja A, Gorham J, Krawitt E, Mieli-Vergani G, Vergani D, Vierling JM. Diagnosis and management of autoimmune hepatitis. Hepatology 2010; 6: 2193-2213.

10. Khalaf H, Mourad W, El-Sheikh Y, Abdo A, Helmy A, Medhat Y, Al-Sofayan M, et al. Liver transplantation for autoimmune hepatitis: a single center experience. Transplant Proc 2007; 39: 1166–1170.

11. Antonini T, Samuel D. Indications et résultats de la greffe hépatique (hors carcinome hépatocellulaire et hépatite fulminante). Gastroenterol Clin Biol 2009; 33: 44-50.

12. Popescu I, Lonescu M, Brasoveanu V, Hrehoret D, Matei E, Dorobantu, Zamfir R et al. Liver transplantation indications, surgical technique, results: the analysis of a clinical series of 200 cases. Chirurgia 2010 Mar-Apr; 105: 177-86.

13. Sociedad Española de Trasplante Hepático. Consensus document of the Spanish Society of Liver Transplantation. Access to liver transplant, indications, controversies, prioritization of waiting lists and quality indicators. Cir Esp 2008; 83: 290-300.

14. Reich D, Fiel I, Guarrera J, Emre S, Guy S, Schwartz M, Miller CM, et al. Liver transplantation for autoimmune hepatitis. Hepatology 2000; 32(4):693-700..

15. Czaja AJ, Carpenter HA. Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly. Hepatology 2006; 43: 532-8.

16. Czaja A. Special clinical challenges in autoimmune hepatitis: the elderly, males, pregnancy, mild disease, fulminant disease and non-white patients. Semin Liver Dis 2009; 29: 315-30.

17. Donaldson PT, Doherty DG, Hayllar KM, McFarlane IG, Johnson PJ, Williams R. Susceptibility to autoimmune chronic active hepatitis: human leucocyte antigens DR4 and A1-B8-DR3 are independent risk factors. Hepatology 1991; 13: 701-706.

18. Narumi K, Hakamada M, Sasaki CE, Freise PG, Stock JP, Roberts NL, Ascher NL. Liver transplantation for autoimmune hepatitis: rejection and recurrence. Transplant Proc 1999; 31: 1955-6.

19. Longi S, Ma Y, Mieli-Vergani G, Vergani D. Aetiopathogenesis of autoimmune hepatitis. J Autoimmun 2010; 34: 7-14.

20. Czaja AJ, Souto EO, Bittencourt PL, Cancado EL, Porta G, Goldberg AC, Donaldson PT. Clinical distinctions and pathogenic implications of type 1 autoimmune hepatitis in Brazil and the United States. J Hepatol 2002; 37: 302-308.

21. Fainboim L, Marcos Y, Pando M, Capucchio M, Reyes GB, Galoppo C, Badia I, et al. Chronic active autoimmune hepatitis in children. Strong association with a particular HLA DR6 (DRB1*1301) haplotype. Hum Immunol 1994; 41: 146-50 [Abstract].

22. Gotz G, Neuhaus R, Bechstein W, Lobeck H, Berg T, Hopf U, Neuhaus P. Recurrence of autoimmune hepatitis after liver transplantation. Transplant Proc 1999; 31: 430-1.

23. Duclos-Valle J, Sebagh M, Rifai K, Johanet C, Ballot E, Guettier C, Karam V, et al. A ten year follow up study of patients transplanted for autoimmune hepatitis: histological recurrence precedes clinical and biochemical recurrence. Gut 2003; 52: 893-897.

24. Ratziu V, Samuel D, Sebagh M, Farges O, Saliba F, Ichai P, Farahmand H, et al. Long term follow up after liver transplantation for autoimmune hepatitis: evidence of recurrence of primary disease. J Hepatol 1999; 30:131-141.

25. Prados E, Cuervas-Mons V, de la Mata M, Fraga E, Rimola A, Prieto M, Clemente G, et al. Outcome of autoimmune hepatitis after liver transplantation. Transplantation 1998; 66: 1645-1650.

26. Milkiewics P, Hubscher S, Skiba G, Hathaway M, Elias E. Recurrence of autoimmune hepatitis after liver transplantation. Transplantation 1999; 68: 253-6.

27. González-Koch A, Czaja AJ, Carpenter HA, Roberts SK, Charlton MR, Porayko MK, Rosen CB, et al. Recurrent autoimmune hepatitis after orthotopic liver transplantation. Liver Transpl 2001; 7: 302-310.

28. Vogel A, Heinrich E, Bahr MJ, Rifai K, Flemming P, Melter M, Klempnauer J et al. Long term outcome of liver transplantation for autoimmune hepatitis. Clin Transplant 2004; 18: 62-69.

29. Gautam M, Cheruvattath R, Balan V. Recurrence of autoimmune liver disease after liver transplantation: a systematic review. Liver Transpl 2006; 12: 1813-24.

30. Montano-Loza A, Mason A, Ma M, Bastiampillai R, Bain V, Tandon P. Risk factors for recurrence of autoimmune hepatitis after liver transplantation. Liver Transpl 2009; 15: 1254-61.